Shikai Zhu

First Ring Road
Chengdu, 610072, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Shaping Precision Medicine: The Journey of Sequencing Technologies Across Human Solid Tumors.

Shaping Precision Medicine: The Journey of Sequencing Technologies Across Human Solid Tumors.

Journal: Biomedicines

Published: September 22, 2025

Unveiling EMC6 as a novel pathogenic determinant in hepatocellular carcinoma: orchestration of lipid metabolism through regulation of lipid droplet-associated enzyme HSD17B13.

Unveiling EMC6 as a novel pathogenic determinant in hepatocellular carcinoma: orchestration of lipid metabolism through regulation of lipid droplet-associated enzyme HSD17B13.

Journal: Oncogene

Published: June 16, 2025

Circular RNA CDR1as/ciRS-7- a novel biomarker in solid tumors.

Circular RNA CDR1as/ciRS-7- a novel biomarker in solid tumors.

Journal: Frontiers in oncology

Published: July 21, 2024

Lactated Ringer's solution versus saline fluid resuscitation for reducing progression to moderate-to-severe acute pancreatitis: a systematic review and meta-analysis.

Lactated Ringer's solution versus saline fluid resuscitation for reducing progression to moderate-to-severe acute pancreatitis: a systematic review and meta-analysis.

Journal: International journal of surgery (London, England)

Published: July 11, 2024

The aryl hydrocarbon receptor: A crucial mediator in ocular disease pathogenesis and therapeutic target.

The aryl hydrocarbon receptor: A crucial mediator in ocular disease pathogenesis and therapeutic target.

Journal: Experimental eye research

Published: July 08, 2024

CDKs Functional Analysis in Low Proliferating Early-Stage Pancreatic Ductal Adenocarcinoma.

CDKs Functional Analysis in Low Proliferating Early-Stage Pancreatic Ductal Adenocarcinoma.

Journal: Journal of bioinformatics and systems biology : Open access

Published: September 25, 2023

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer.

HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer.

Journal: Theranostics

Published: November 25, 2021

Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation.

Pseudogene AK4P1 promotes pancreatic ductal adenocarcinoma progression through relieving miR-375-mediated YAP1 degradation.

Journal: Aging

Published: November 01, 2021

Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer.

Overexpressed WDR3 induces the activation of Hippo pathway by interacting with GATA4 in pancreatic cancer.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 05, 2020

FBP1 binds to the bromodomain of BRD4 to inhibit pancreatic cancer progression.

FBP1 binds to the bromodomain of BRD4 to inhibit pancreatic cancer progression.

Journal: American journal of cancer research

Published: December 05, 2019

USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1.

USP44 suppresses pancreatic cancer progression and overcomes gemcitabine resistance by deubiquitinating FBP1.

Journal: American journal of cancer research

Published: June 14, 2019

Association between HOTAIR polymorphisms and cancer risk：a meta-analysis based on twenty-one case-control studies.

Association between HOTAIR polymorphisms and cancer risk：a meta-analysis based on twenty-one case-control studies.

Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology

Published: April 04, 2019

Showing 1-12 of 19

Last Updated: 09/26/2026